Dr. Whitman on Expanding the Benefit of Immunotherapy in Solid Tumors

Video

In Partnership With:

Eric Whitman, MD, medical director of Atlantic Health System Cancer Care, Atlantic Health System, discusses ways to expand the benefit of immunotherapy in non-immunogenic solid tumors.

Eric Whitman, MD, medical director of Atlantic Health System Cancer Care, Atlantic Health System, discusses ways to expand the benefit of immunotherapy in nonimmunogenic solid tumors.

At Morristown Medical Center’s 7th Annual Joseph Calello Melanoma Scholar presentation, Adil Daud, MD, of the University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, discussed ways to turn “cold” tumors into “hot” tumors. Atlantic Health System is conducting several trials looking at the role of interleukin (IL)-12 in increasing the immunogenicity of a tumor. In these trials, patients who have failed multiple lines of therapy are treated with anti—PD-1 agents and IL-12 via electroporation.

Other ongoing work is assessing T cell response to immunotherapy. In the cases of “cold” tumors, researchers believe the T cells become exhausted and are unable to generate an immune response. If researchers can use IL-12 to reactivate the T cells remains to be seen, Whitman concludes.

Related Videos
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania
Sara Corvigno, MD, PhD, translational researcher, oncology, The University of Texas MD Anderson Cancer Center
I-Chia (Daniel) Liu, MD
Robert W. Mutter, MD
Saad J. Kenderian, MB, CHB, consultant, Division of Hematology, Department of Internal Medicine, Department of Immunology, Department of Molecular Medicine, assistant professor, oncology, immunology, medicine, Mayo Clinic
Mary-Ellen Taplin, MD